Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Ovarian Cancer
Related studies linked through entity extraction aliases.
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2